tirzepatide new england journal of medicine A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Tirzepatide vs Dulaglutide in T2D

107 LluisJ

There are concerns about potential fetal malformations associated with Ozempic use during pregnancy

Skin Reactions In rare cases, Fluconazole can cause Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN)

Abstract Background The prevalence of obesity has been increasing worldwide, with substantial implications for public health

Pharmacokinetic Modelling Pharmacokinetic modelling was used to simulate the pharmacokinetic profiles at steady state based on the observed pharmacokinetic results of the present single-dose study

Changes in the brains reward system reduce the intensity of cravings and the urge to act on food-related thoughts